Veracyte holder Muna Bhanji plans 3,728-share sale

Rhea-AI Filing Summary

VERACYTE, INC. (VCYT) is the issuer of common stock that Muna Bhanji plans to sell under Rule 144. The notice covers 3,728 shares of Veracyte common stock to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value listed as $161,012.32 and a proposed sale date of September 1, 2026. The securities to be sold originated from Restricted Stock Units granted by the issuer with an acquisition date of June 18, 2026.

Key Figures

Shares to be sold: 3,728 shares of common stock Aggregate market value: $161,012.32 Proposed sale date: 09/01/2026 +1 more

4 metrics

Shares to be sold 3,728 shares of common stock Amount of Veracyte common stock covered by the Rule 144 notice

Aggregate market value $161,012.32 Reported market value of the 3,728 shares to be sold

Proposed sale date 09/01/2026 Date listed for the proposed sale of the shares

Acquisition date of securities 06/18/2026 Date RSU-based common stock was acquired from the issuer

Key Terms

Rule 144, Restricted Stock Units, Executive Financial Services

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Units financial

"Common | 06/18/2026 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Executive Financial Services financial

"Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza"

FAQ

What does the Form 144 filing indicate for VERACYTE, INC. (VCYT)?

The filing indicates that 3,728 shares of Veracyte common stock may be sold by Muna Bhanji under Rule 144, through Morgan Stanley Smith Barney LLC, with an aggregate market value of $161,012.32 and a proposed sale date of September 1, 2026.

How many VCYT shares are covered by this Form 144 notice?

The notice covers 3,728 shares of Veracyte, Inc. common stock. These shares are listed as the amount of securities to be sold under Rule 144 as of the proposed transaction disclosed in the filing.

What is the aggregate market value of the VCYT shares to be sold?

The filing reports an aggregate market value of $161,012.32 for the 3,728 shares of Veracyte common stock that are proposed to be sold under Rule 144.

When are the VCYT shares proposed to be sold under this Form 144?

The proposed sale date for the Veracyte common stock under this Form 144 is September 1, 2026, as shown in the securities information section of the notice.

What is the source and type of VCYT securities being sold?

The securities are Veracyte common stock obtained from Restricted Stock Units granted by the issuer, with an acquisition date of June 18, 2026, as disclosed in the securities-to-be-sold section.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/01/2026 - 04:42 PM Accepted by SEC EDGAR 09/01/2026 - 04:42 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001846905
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	VERACYTE INC
SEC File Number	001-36156
Address of Issuer	6000 Shoreline Court, Suite 300 South San Francisco CALIFORNIA 94080
Phone	6502436300
Name of Person for Whose Account the Securities are To Be Sold	MUNA BHANJI
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3728	161012.32	80390731	09/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/18/2026	Restricted Stock Units	Issuer			3728	06/18/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/02/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Muna Bhanji
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)